Mild chronic anemia following heart transplantation: a syndrome with prognostic relevance?
- 作者H. M. Müller; Reingard Aigner; Jörg H. Horina; Peter Rehak; Thomas Lang; Florian Iberer; Andre Wasler; Berthold Petutschnigg; Thomas Allmayer; Barbara Grasser; Günter Prenner; Silvia Schaffellner; Karl-Heinz Tscheliessnigg
- 卷第11卷
- 期第6期
- 印刷ISSN0934-0874
- 电子ISSN1432-2277
- 文件大小71.85KB
- 发表时间1998-12
- DOI10.1007/s001470050167
- 页码413-418
Alemtuzumab as Antirejection TherapyBouvy, Anne P.; Klepper, Mariska; Betjes, Michiel G.H.; Weimar, Willem; Hesselink, Dennis A.; Baan, Carla C. · Transplantation Direct · 2016
Cover Picture: Eur. J. Immunol. 12/09Monique E. Quaedackers; Carla C. Baan; Willem Weimar; Martin J. Hoogduijn · 2009
Intragraft cytokine gene expression: implications for clinical transplantationCarla C. Baan; Willem Weimar · 1998
Targeting the IL-15 pathway to prevent rejection after organ transplantationCarla C. Baan; Willem Weimar · 2006
Clinical impact of cytokine gene polymorphisms in heart and lung transplantationCecile T.J. Holweg; Willem Weimar; André G. Uitterlinden; Carla C. Baan · 2004
Regulatory T cells after organ transplantation: Where does their action take place?I. Esmé Dijke; Willem Weimar; Carla C. Baan · 2008
Pharmacodynamic Analysis of Tofacitinib and Basiliximab in Kidney Allograft RecipientsVafadari, Ramin; Quaedackers, Monique E.; Kho, Marcia M.; Mol, Wendy M.; Chan, Gary; Weimar, Willem; Baan, Carla C. · Transplantation Journal · 2012